Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$132M |
| 2 |
Newmont
NEM
|
+$67.7M |
| 3 |
Corteva
CTVA
|
+$65.9M |
| 4 |
Amcor
AMCR
|
+$58.2M |
| 5 |
Alibaba
BABA
|
+$48.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$128M |
| 2 |
Apple
AAPL
|
+$93M |
| 3 |
GG
Goldcorp Inc
GG
|
+$78.3M |
| 4 |
Microsoft
MSFT
|
+$73.5M |
| 5 |
Pfizer
PFE
|
+$52.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.91% |
| 2 | Healthcare | 14.68% |
| 3 | Consumer Discretionary | 11.95% |
| 4 | Communication Services | 10.15% |
| 5 | Industrials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WAIR
2051
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $1.13M | ﹤0.01% |
102,000
+2,300
| +2% | +$22.1K |
|
|
STFC
2052
DELISTED
State Auto Financial Corp
STFC
| $1.13M | ﹤0.01% |
32,300
+900
| +3% | +$30.6K |
|
|
ITCI
2053
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.13M | ﹤0.01% |
86,900
+7,100
| +9% | +$91.1K |
|
|
HMHC
2054
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $1.13M | ﹤0.01% |
195,600
+4,200
| +2% | +$27.9K |
|
2055
Koppers
KOP
$956M
| $1.12M | ﹤0.01% |
38,200
+1,600
| +4% | +$44.6K |
|
2056
Peoples Bancorp
PEBO
$1.46B
| $1.12M | ﹤0.01% |
34,600
+2,600
| +8% | +$83K |
|
2057
Axsome Therapeutics
AXSM
$11.4B
| $1.11M | ﹤0.01% |
+43,300
| New | +$868K |
|
2058
Horizon Bancorp
HBNC
$1.03B
| $1.11M | ﹤0.01% |
67,850
+1,400
| +2% | +$22.6K |
|
|
AEGN
2059
DELISTED
Aegion Corp
AEGN
| $1.11M | ﹤0.01% |
60,200
+1,300
| +2% | +$22.1K |
|
|
WLH
2060
DELISTED
WILLIAM LYON HOMES
WLH
| $1.11M | ﹤0.01% |
60,800
+1,100
| +2% | +$19.8K |
|
|
AD
2061
Array Digital Infrastructure
AD
$3.03B
| $1.1M | ﹤0.01% |
24,700
+700
| +3% | +$32.7K |
|
|
REGI
2062
DELISTED
Renewable Energy Group, Inc.
REGI
| $1.1M | ﹤0.01% |
69,400
+8,200
| +13% | +$151K |
|
|
CTRL
2063
DELISTED
Control4 Corporation
CTRL
| $1.1M | ﹤0.01% |
46,300
| – | – |
|
|
FFIC
2064
DELISTED
Flushing Financial
FFIC
| $1.1M | ﹤0.01% |
49,423
+1,700
| +4% | +$37.5K |
|
2065
BrightView Holdings
BV
$1.05B
| $1.1M | ﹤0.01% |
58,600
+11,000
| +23% | +$184K |
|
2066
Gorman-Rupp
GRC
$2.16B
| $1.09M | ﹤0.01% |
33,947
+700
| +2% | +$22.7K |
|
2067
Origin Bancorp
OBK
$1.64B
| $1.09M | ﹤0.01% |
33,182
+900
| +3% | +$30.6K |
|
2068
Veeco
VECO
$3.02B
| $1.09M | ﹤0.01% |
89,421
+2,300
| +3% | +$27.9K |
|
2069
RadNet
RDNT
$6.08B
| $1.09M | ﹤0.01% |
79,200
+3,500
| +5% | +$44.9K |
|
2070
Weis Markets
WMK
$1.78B
| $1.09M | ﹤0.01% |
30,000
+5,500
| +22% | +$216K |
|
2071
Tucows
TCX
$142M
| $1.09M | ﹤0.01% |
17,800
+1,400
| +9% | +$101K |
|
|
COOP
2072
DELISTED
Mr. Cooper
COOP
| $1.08M | ﹤0.01% |
135,200
-5,500
| -4% | -$46.3K |
|
2073
Allegiant Air
ALGT
$2.41B
| $1.08M | ﹤0.01% |
7,528
+200
| +3% | +$28K |
|
|
SRDX
2074
DELISTED
Surmodics
SRDX
| $1.08M | ﹤0.01% |
25,000
+600
| +2% | +$25.3K |
|
|
ECHO
2075
DELISTED
Echo Global Logistics, Inc.
ECHO
| $1.08M | ﹤0.01% |
51,700
+2,200
| +4% | +$48.8K |
|
Similar funds
Swiss National Bank's Q2 2019 Portfolio in Review
As of Q2 2019, Swiss National Bank held 2,619 positions worth $92.7B, up 1.7% from $91.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Swiss National Bank's Q2 2019 filing shows 112 new, 1,554 increased, 696 reduced and 65 closed positions. Its largest new stake was Dow Inc: 2,494,044 shares worth $123M. The largest sale was DuPont de Nemours, an estimated $128M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2019 buy was Dow Inc: 2,494,044 shares worth $123M.
- Swiss National Bank added most to Newmont in Q2 2019, an estimated $67.7M increase.
- Swiss National Bank's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $128M.
- Swiss National Bank fully exited Goldcorp Inc in Q2 2019, selling an estimated $78.3M.
- Swiss National Bank's ten largest holdings make up 18% of its $92.7B portfolio in Q2 2019.
- Swiss National Bank opened 112 new positions and closed 65 in Q2 2019.
- Swiss National Bank's portfolio value rose 1.7% quarter-over-quarter to $92.7B.
Based on Swiss National Bank's 13F filing for Q2 2019, filed 2 Aug 2019.